SyntheticMR has entered a general software license agreement for distribution with Siemens Healthineers. The agreement enables Siemens Healthineers to market, sell and distribute SyntheticMR’s product package, SyMRI Neuro—used to create quantitative magnetic resonance imaging (MRI) scans of the brain—to its customers in various markets globally including in the USA, CE-certification markets in Europe, Japan, India, Brazil, Saudi Arabia, and Australia and New Zealand.
SyntheticMR and Siemens Healthineers signed a cooperation agreement in 2016 and, since 2018, SyMRI Neuro has been available for purchase on the Siemens Healthineers Digital Marketplace. The product can be seamlessly integrated into the clinical workflow, according to a SyntheticMR press release. In addition, SyMRI Neuro can now be purchased together with Magnetom MRI scanners directly from Siemens Healthineers.
“This license agreement is an important step towards a deeper collaboration with Siemens Healthineers on a global level,” said SyntheticMR CEO Ulrik Harrysson. “We see a high level of interest in our medical imaging solutions to further enhance MRI workflows and provide decision support, and we are pleased to work together with Siemens Healthineers to bring this to the global market. The agreement represents a significant addition to our sales resources and enables us to further support our customers and healthcare providers worldwide.”
“Through our partnership with SyntheticMR, we are further transforming syngo.via and Syngo Carbon into an independent, advanced visualisation platform, while extending our reading and reporting solution,” said Oliver Klinkow, vice-president of Marketing and Sales at Syngo. “We are excited to see the SyMRI Neuro functionality available as part of our solution.”